Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients

Transplantation. 1994 Aug 15;58(3):370-2.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Arteriosclerosis / epidemiology
  • Arteriosclerosis / etiology
  • Cyclosporine / therapeutic use
  • Diabetes Mellitus / chemically induced*
  • Diabetes Mellitus / etiology
  • Dose-Response Relationship, Drug
  • Female
  • Glucose Tolerance Test
  • Graft Rejection / prevention & control
  • Humans
  • Liver Transplantation / adverse effects
  • Liver Transplantation / immunology*
  • Male
  • Middle Aged
  • Risk Factors
  • Tacrolimus / administration & dosage
  • Tacrolimus / adverse effects*
  • Tacrolimus / therapeutic use

Substances

  • Cyclosporine
  • Tacrolimus